Evidence map›Paper›PMID 33637754›Full record

ArticleNature communications2021

Neuromodulation of the cerebellum rescues movement in a mouse model of ataxia.

Lauren N Miterko, Tao Lin, Joy Zhou, Meike E van der Heijden, Jaclyn Beckinghausen, Joshua J White, Roy V Sillitoe

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Stem cell models in ataxia-telangiectasia.Neural regeneration research · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Axonal pathology differentially affects human Purkinje cell subpopulations in the essential tremor cerebellum.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Thalamic deep brain stimulation improves movement in a cerebellar model of lesion-based status dystonicus.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  12. Article
  13. Cerebellar deep brain stimulation as a dual-function therapeutic for restoring movement and sleep in dystonic mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  14. Cerebellar Functions Beyond Movement and Learning.Annual review of neuroscience · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lauren N MiterkoDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Tao LinDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6441-067X
Joy ZhouDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Meike E van der HeijdenDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0003-0801-8806
Jaclyn BeckinghausenDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Joshua J WhiteDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Roy V SillitoeDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. sillitoe@bcm.edu.ORCID http://orcid.org/0000-0002-6177-6190
Baylor College of Medicine · US

Funding

Preclinical and Clincial OutcomesP50HD103555 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Sandesh Chakravarthy Sreenath Nagamani, David Loren Nelson · 2020 to 2026
$9.9M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, NEUL, JEFFREY L · 2014 to 2019
$7.8M
CEREBELLAR FUNCTION IN TREMORR01NS100874 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SILLITOE, ROY VINCENT · 2017 to 2021
$1.9M
SYNAPTIC ORIGINS OF CEREBELLAR DISEASER01NS089664 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SILLITOE, ROY VINCENT · 2014 to 2018
$1.7M
NICHD NIH HHS P50 HD103555NICHD NIH HHS U54 HD083092NINDS NIH HHS R01 NS089664NINDS NIH HHS R01 NS100874
6 · The paper itself

Abstract

Deep brain stimulation (DBS) relieves motor dysfunction in Parkinson's disease, and other movement disorders. Here, we demonstrate the potential benefits of DBS in a model of ataxia by targeting the cerebellum, a major motor center in the brain. We use the Car8 mouse model of hereditary ataxia to test the potential of using cerebellar nuclei DBS plus physical activity to restore movement. While low-frequency cerebellar DBS alone improves Car8 mobility and muscle function, adding skilled exercise to the treatment regimen additionally rescues limb coordination and stepping. Importantly, the gains persist in the absence of further stimulation. Because DBS promotes the most dramatic improvements in mice with early-stage ataxia, we postulated that cerebellar circuit function affects stimulation efficacy. Indeed, genetically eliminating Purkinje cell neurotransmission blocked the ability of DBS to reduce ataxia. These findings may be valuable in devising future DBS strategies.

Indexed as

AnimalsBiomarkers, TumorCarbonic AnhydrasesCerebellar AtaxiaCerebellar NucleiCerebellumDisease Models, AnimalFemaleMaleMiceMovementNerve Tissue ProteinsParkinson DiseasePurkinje CellsSynaptic TransmissionBiomarkers, TumorCar8 protein, mouseCarbonic AnhydrasesNerve Tissue Proteins

Identifiers

PMID33637754
PMCPMC7910465
OpenAlexW3130566834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.